Clinical trial
A Study to Evaluate Rituximab in Combination With Methotrexate in…
NCT00299104 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00299104 |
|---|---|
| Title | A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis |
| Official title | A Randomized, Phase 3, Controlled, Double-Blind, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate (MTX) Compared to MTX Alone, in Methotrexate-Naive Patients With Active Rheumatoid Arthritis |
| Acronym | IMAGE |
| Lead sponsor | Genentech, Inc., Industry |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | folate, methotrexate, methylprednisolone, placebo, rituximab |
| Enrollment | 755 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Jul 1, 2013 |
| First posted | Mar 6, 2006 |
| Last update posted | Jul 28, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: